Camptosar Overdose, Contraindications and Information - Irinotecan hydrochloride

Camptosar Overdose, Contraindications and Information - Irinotecan hydrochloride

OVERDOSE

In U.S. phase 1 trials, single doses of up to 345 mg/m² of irinotecan were administered to patients with various cancers. Single doses of up to 750 mg/m² of irinotecan have been given in non-U.S. trials. The adverse events in these patients were similar to those reported with the recommended dosage and regimen. There is no known antidote for overdosage of CAMPTOSAR. Maximum supportive care should be instituted to prevent dehydration due to diarrhea and to treat any infectious complications.

CAMPTOSAR Injection is contraindicated in patients with a known hypersensitivity to the drug.